Abstract
BackgroundReactive arthritis is still a matter of interest and a current problem, since its treatment is not standardized, with the possibility of a chronic evolution. Nevertheless, anti TNF agents may...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have